Identification of PDGFR as a receptor for AAV-5 transduction
10.1038/nm929
Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., & Chiorini, J. A. (2003). Identification of PDGFR as a receptor for AAV-5 transduction. Nature Medicine, 9(10), 1306–1312.

Authors 7
  1. Giovanni Di Pasquale (first)
  2. Beverly L Davidson (additional)
  3. Colleen S Stein (additional)
  4. Inês Martins (additional)
  5. Dominic Scudiero (additional)
  6. Anne Monks (additional)
  7. John A Chiorini (additional)
References 40 Referenced 295
  1. Bantel-Schaal, U., Delius, H., Schmidt, R. & zur Hausen, H. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J. Virol. 73, 939–947 (1999). (10.1128/JVI.73.2.939-947.1999) / J. Virol. by U Bantel-Schaal (1999)
  2. Chiorini, J.A., Kim, F., Yang, L. & Kotin, R.M. Cloning and characterization of adeno-associated virus type 5. J. Virol. 73, 1309–1319 (1999). (10.1128/JVI.73.2.1309-1319.1999) / J. Virol. by JA Chiorini (1999)
  3. Chiorini, J.A., Yang, L., Liu, Y., Safer, B. & Kotin, R.M. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J. Virol. 71, 6823–6833 (1997). (10.1128/JVI.71.9.6823-6833.1997) / J. Virol. by JA Chiorini (1997)
  4. Muramatsu, S., Mizukami, H., Young, N.S. & Brown, K.E. Nucleotide sequencing and generation of an infectious clone of adeno- associated virus 3. Virology 221, 208–217 (1996). (10.1006/viro.1996.0367) / Virology by S Muramatsu (1996)
  5. Rutledge, E.A., Halbert, C.L. & Russell, D.W. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72, 309–319 (1998). (10.1128/JVI.72.1.309-319.1998) / J. Virol. by EA Rutledge (1998)
  6. Xiao, W. et al. Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994–4003 (1999). (10.1128/JVI.73.5.3994-4003.1999) / J. Virol. by W Xiao (1999)
  7. Gao, G.P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 11854–11859 (2002). (10.1073/pnas.182412299) / Proc. Natl. Acad. Sci. USA by GP Gao (2002)
  8. Qing, K. et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5, 71–77 (1999). (10.1038/4758) / Nat. Med. by K Qing (1999)
  9. Mizukami, H., Young, N.S. & Brown, K.E. Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology 217, 124–130 (1996). (10.1006/viro.1996.0099) / Virology by H Mizukami (1996)
  10. Summerford, C., Bartlett, J.S. & Samulski, R.J. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78–82 (1999). (10.1038/4768) / Nat. Med. by C Summerford (1999)
  11. Summerford, C. & Samulski, R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438–1445 (1998). (10.1128/JVI.72.2.1438-1445.1998) / J. Virol. by C Summerford (1998)
  12. Davidson, B.L. et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 97, 3428–3432 (2000). (10.1073/pnas.97.7.3428) / Proc. Natl. Acad. Sci. USA by BL Davidson (2000)
  13. Rabinowitz, J.E. et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76, 791–801 (2002). (10.1128/JVI.76.2.791-801.2002) / J. Virol. by JE Rabinowitz (2002)
  14. Zabner, J. et al. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74, 3852–3858 (2000). (10.1128/JVI.74.8.3852-3858.2000) / J. Virol. by J Zabner (2000)
  15. Hildinger, M. et al. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75, 6199–6203 (2001). (10.1128/JVI.75.13.6199-6203.2001) / J. Virol. by M Hildinger (2001)
  16. Kaludov, N., Brown, K.E., Walters, R.W., Zabner, J. & Chiorini, J.A. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75, 6884–6893 (2001). (10.1128/JVI.75.15.6884-6893.2001) / J. Virol. by N Kaludov (2001)
  17. Walters, R.W. et al. Binding of Adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276, 20610–20616 (2001). (10.1074/jbc.M101559200) / J. Biol. Chem. by RW Walters (2001)
  18. Ross, D.T. et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24, 227–235 (2000). (10.1038/73432) / Nat. Genet. by DT Ross (2000)
  19. Zaharevitz, D.W., Holbeck, S.L., Bowerman, C. & Svetlik, P.A. COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition. J. Mol. Graph. Model. 20, 297–303 (2002). (10.1016/S1093-3263(01)00126-7) / J. Mol. Graph. Model. by DW Zaharevitz (2002)
  20. Paull, K.D. et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. 81, 1088–1092 (1989). (10.1093/jnci/81.14.1088) / J. Natl. Cancer Inst. by KD Paull (1989)
  21. Yarden, Y. & Ullrich, A. Growth factor receptor tyrosine kinases. Annu. Rev. Biochem. 57, 443–478 (1988). (10.1146/annurev.bi.57.070188.002303) / Annu. Rev. Biochem. by Y Yarden (1988)
  22. Williams, L.T. Signal transduction by the platelet-derived growth factor receptor involves association of the receptor with cytoplasmic molecules. Clin. Res. 37, 564–568 (1989). / Clin. Res. by LT Williams (1989)
  23. Matsui, T. et al. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243, 800–804 (1989). (10.1126/science.2536956) / Science by T Matsui (1989)
  24. Rosenfeld, M.E., Bowen-Pope, D.F. & Ross, R. Platelet-derived growth factor: morphologic and biochemical studies of binding, internalization, and degradation. J. Cell. Physiol. 121, 263–274 (1984). (10.1002/jcp.1041210202) / J. Cell. Physiol. by ME Rosenfeld (1984)
  25. Nilsson, J., Thyberg, J., Heldin, C.H., Westermark, B. & Wasteson, A. Surface binding and internalization of platelet-derived growth factor in human fibroblasts. Proc. Natl. Acad. Sci. USA 80, 5592–5596 (1983). (10.1073/pnas.80.18.5592) / Proc. Natl. Acad. Sci. USA by J Nilsson (1983)
  26. Wang, Y.Z., Zhang, P., Rice, A.B. & Bonner, J.C. Regulation of interleukin-1beta -induced platelet-derived growth factor receptor-alpha expression in rat pulmonary myofibroblasts by p38 mitogen-activated protein kinase. J. Biol. Chem. 275, 22550–22557 (2000). (10.1074/jbc.M909785199) / J. Biol. Chem. by YZ Wang (2000)
  27. Fessler, M.B., Malcolm, K.C., Duncan, M.W. & Worthen, G.S. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J. Biol. Chem. 277, 31291–31302 (2002). (10.1074/jbc.M200755200) / J. Biol. Chem. by MB Fessler (2002)
  28. Scherf, U. et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24, 236–244 (2000). (10.1038/73439) / Nat. Genet. by U Scherf (2000)
  29. Lee, J.S. et al. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol. 46, 627–638 (1994). / Mol. Pharmacol. by JS Lee (1994)
  30. Koo, H.M. et al. Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res. 56, 5211–5216 (1996). / Cancer Res. by HM Koo (1996)
  31. Georg-Fries, B., Biederlack, S., Wolf, J. & zur Hausen, H. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 134, 64–71 (1984). (10.1016/0042-6822(84)90272-1) / Virology by B Georg-Fries (1984)
  32. Su, A.I. et al. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA 99, 4465–4470 (2002). (10.1073/pnas.012025199) / Proc. Natl. Acad. Sci. USA by AI Su (2002)
  33. Diehn, M. et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 31, 219–223 (2003). (10.1093/nar/gkg014) / Nucleic Acids Res. by M Diehn (2003)
  34. Alisky, J.M. et al. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11, 2669–2673 (2000). (10.1097/00001756-200008210-00013) / Neuroreport by JM Alisky (2000)
  35. Oumesmar, B.N., Vignais, L. & Baron-Van Evercooren, A. Developmental expression of platelet-derived growth factor alpha-receptor in neurons and glial cells of the mouse CNS. J. Neurosci. 17, 125–139 (1997). (10.1523/JNEUROSCI.17-01-00125.1997) / J. Neurosci. by BN Oumesmar (1997)
  36. Hosang, M. Characterization of a platelet-derived growth factor receptor on Swiss 3T3 cells by affinity crosslinking. J. Recept. Res. 8, 455–466 (1988). (10.3109/10799898809049004) / J. Recept. Res. by M Hosang (1988)
  37. Daniel, T.O., Milfay, D.F., Escobedo, J. & Williams, L.T. Biosynthetic and glycosylation studies of cell surface platelet-derived growth factor receptors. J. Biol. Chem. 262, 9778–9784 (1987). (10.1016/S0021-9258(18)48001-5) / J. Biol. Chem. by TO Daniel (1987)
  38. Wickham, T.J., Mathias, P., Cheresh, D.A. & Nemerow, G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73, 309–319 (1993). (10.1016/0092-8674(93)90231-E) / Cell by TJ Wickham (1993)
  39. Kapeller, R., Chakrabarti, R., Cantley, L., Fay, F. & Corvera, S. Internalization of activated platelet-derived growth factor receptor- phosphatidylinositol-3′ kinase complexes: potential interactions with the microtubule cytoskeleton. Mol. Cell. Biol. 13, 6052–6063 (1993). (10.1128/MCB.13.10.6052) / Mol. Cell. Biol. by R Kapeller (1993)
  40. Bantel-Schaal, U., Hub, B. & Kartenbeck, J. Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment. J. Virol. 76, 2340–2349 (2002). (10.1128/jvi.76.5.2340-2349.2002) / J. Virol. by U Bantel-Schaal (2002)
Dates
Type When
Created 21 years, 11 months ago (Sept. 22, 2003, 10:14 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:35 p.m.)
Indexed 1 week ago (Aug. 26, 2025, 2:56 a.m.)
Issued 21 years, 11 months ago (Sept. 14, 2003)
Published 21 years, 11 months ago (Sept. 14, 2003)
Published Online 21 years, 11 months ago (Sept. 14, 2003)
Published Print 21 years, 11 months ago (Oct. 1, 2003)
Funders 0

None

@article{Pasquale_2003, title={Identification of PDGFR as a receptor for AAV-5 transduction}, volume={9}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/nm929}, DOI={10.1038/nm929}, number={10}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Pasquale, Giovanni Di and Davidson, Beverly L and Stein, Colleen S and Martins, Inês and Scudiero, Dominic and Monks, Anne and Chiorini, John A}, year={2003}, month=sep, pages={1306–1312} }